Frontiers in pharmacology

Sodium oligomannate may reduce brain damage and improve nerve function by changing gut bacteria in rats with stroke

Updated

Abstract

Sodium oligomannate (GV-971) targets the gut-brain axis and may alleviate gliosis and cognitive dysfunction.

  • Ischemic stroke is the second leading cause of death globally and has a limited treatment window for thrombolysis.
  • Gut microbiota imbalances and gliosis are significant contributors to neurological impairment after ischemic stroke.
  • GV-971 has shown promise in remodeling gut microbiota in Alzheimer's disease.
  • The pharmacological effects of GV-971 on ischemic stroke remain unexamined.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

No commercial or financial ties reported.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free